Phytopharm Consulting Brazil
Quick facts
Phase 3 pipeline
- Aplause® · Immunology
Aplause is a small molecule that targets the sphingosine-1-phosphate receptor 1 (S1PR1) to modulate immune responses. - Cimicifuga Herbarium · Women's Health / Menopause
Cimicifuga (black cohosh) herbarium extract modulates estrogen receptor signaling and reduces vasomotor symptoms through phytoestrogen activity. - Cimicifuga + Hiperico · Women's Health / Menopause
This herbal combination product uses Cimicifuga (black cohosh) and Hypericum (St. John's Wort) to modulate serotonergic and hormonal pathways, potentially alleviating menopausal symptoms and mood disturbances. - GAMALINE® · Psychiatry
GAMALINE is a medication used to treat attention deficit hyperactivity disorder (ADHD). - GAMALINE® + HIPERICIN® · Immunology / Inflammation
GAMALINE® + HIPERICIN® is a phytopharmaceutical combination that enhances immune function and reduces inflammatory markers through polyphenolic and flavonoid constituents. - NEDAX · Psychiatry
Nedax is a small molecule drug that targets the serotonin receptor. - PIOLIN® · Rheumatology
PIOLIN is a small molecule that acts as a selective inhibitor of the enzyme responsible for the production of a key inflammatory mediator.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Phytopharm Consulting Brazil
What is Phytopharm Consulting Brazil's pipeline?
Phytopharm Consulting Brazil has 7 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Aplause®, Cimicifuga Herbarium, Cimicifuga + Hiperico, GAMALINE®.
Related
- Sector hub: All tracked pharma companies